Loading…
Chinese maker of feminine hygiene products (sanitary napkins) sold under regional brands including Free Point.
Chinese maker of feminine hygiene products (sanitary napkins) sold under regional brands including Free Point.
Sells sanitary napkins and related items mostly through distributors to supermarkets and convenience stores, and increasingly through online platforms. Raw materials such as pulp and non-woven fabrics make up much of its cost, so margins follow those prices.
In one line: A Chinese feminine-hygiene products maker, akin to a regional Kotex/Always challenger.
Moat: narrow (brand, distribution). Strong regional Southwest China brand and distribution before national expansion via e-commerce.
Headquarters: Chongqing, China · Employees: 2,682
Size Chongqing Baiya Sanitary Products (003006.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $1.49B, the 1650th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥23.09 on 6 Nov 2026.
Performance Over six months the shares gained 24.7%, against -3.2% for the median peer and -16.4% for the China market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 0.2% over the last twelve months (peer median +8.0%); the operating margin is 3.0% (peer median 9.2%).
Valuation It trades at 41.2× forward earnings against a peer median of 18.8× (2nd most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is +8 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 6.3 points above its cost of capital (8.5% WACC).
Next results Next results expected around 22 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥3.56B | CN¥3.47B | CN¥3.23B | CN¥2.13B | CN¥1.60B |
| Revenue growth | — | +7% | +52% | +33% | — |
| Gross profit | CN¥2.05B | CN¥1.86B | CN¥1.70B | CN¥1.06B | CN¥709M |
| EBITDA | n/a | CN¥328M | CN¥361M | CN¥303M | CN¥255M |
| Net income | CN¥101M | CN¥208M | CN¥288M | CN¥238M | CN¥187M |
| Free cash flow | CN¥148M | CN¥65.9M | CN¥174M | CN¥248M | CN¥205M |
| Capital expenditure | CN¥98.3M | CN¥134M | CN¥151M | CN¥83.6M | CN¥28.3M |
| Total debt | CN¥36.2M | CN¥6.00M | CN¥14.4M | CN¥24.7M | CN¥18.6M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Chongqing Baiya Sanitary Products 003006.SZ | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% |
| Hengan Int'l 1044.HK | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% |
| Kimberly-Clark KMB | $66.5B | +12% | -12% | 14% | 15.3× | 4.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 003006.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.0% | +1.6% | 9th highest of 21 |
| 6-month return | +24.7% | -3.2% | 4th highest of 21 |
| Distance from 52-week high | -7.6% | -31.5% | 4th highest of 21 |
| Revenue growth (TTM) | +0.2% | +8.0% | 5th lowest of 21 |
| Operating margin | 3.0% | 9.2% | 4th lowest of 21 |
| Forward P/E | 41.2× | 18.8× | 2nd most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 30.6% | 4.3% | most demanding of 17 |
| Growth delivered (Del g) | +22.8% | +5.8% | 3rd highest of 17 |
| Hurdle (Req g minus delivered) | +7.7 pp | -6.9 pp | 4th most demanding of 17 |
| ROIC minus cost of capital | +6.3 pp | +4.6 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |